DOI QR코드

DOI QR Code

Oral manifestation and root canal therapy of the patient with mucopolysaccharidosis

  • Yoon, Ji-Hye (Department of Conservative Dentistry, School of Dentistry, Dental Science Research Institute, Chonnam National University) ;
  • Lee, Hyo-Il (Department of Conservative Dentistry, School of Dentistry, Dental Science Research Institute, Chonnam National University) ;
  • Jang, Ji-Hyun (Department of Conservative Dentistry, School of Dentistry, Kyung Hee University) ;
  • Choi, Sung-Hyeon (Department of Conservative Dentistry, School of Dentistry, Dental Science Research Institute, Chonnam National University) ;
  • Chang, Hoon-Sang (Department of Conservative Dentistry, School of Dentistry, Dental Science Research Institute, Chonnam National University) ;
  • Hwang, Yun-Chan (Department of Conservative Dentistry, School of Dentistry, Dental Science Research Institute, Chonnam National University) ;
  • Hwang, In-Nam (Department of Conservative Dentistry, School of Dentistry, Dental Science Research Institute, Chonnam National University) ;
  • Lee, Bin-Na (Department of Conservative Dentistry, School of Dentistry, Dental Science Research Institute, Chonnam National University) ;
  • Oh, Won-Mann (Department of Conservative Dentistry, School of Dentistry, Dental Science Research Institute, Chonnam National University)
  • Received : 2018.11.13
  • Accepted : 2019.02.26
  • Published : 2019.05.31

Abstract

Mucopolysaccharidosis (MPS) is an inherited metabolic disorder caused by a deficiency in enzymes that participate in the degradation of glycosaminoglycans (GAGs) such as heparin sulfate and dermatan sulfate. Left untreated, patients show progressive mental and physical deterioration due to deposition of GAGs in organs. Death often occurs due to cardiac or respiratory failure before patients reach their early twenties. MPS has several oral and dental manifestations. An enlarged head, short neck, and open mouth associated with a large tongue are major characteristics of MPS patients. Dental complications can be severe, including unerupted dentition, dentigerous cyst-like follicles, malocclusions, condylar defects, and gingival hyperplasia. A 21-year-old female patient with MPS was described in this article, with special emphasis on oral manifestations and dental treatment.

Keywords

References

  1. Lehman TJ, Miller N, Norquist B, Underhill L, Keutzer J. Diagnosis of the mucopolysaccharidoses. Rheumatology (Oxford) 2011;50 Suppl 5:v41-v48. https://doi.org/10.1093/rheumatology/ker390
  2. Baehner F, Schmiedeskamp C, Krummenauer F, Miebach E, Bajbouj M, Whybra C, Kohlschutter A, Kampmann C, Beck M. Cumulative incidence rates of the mucopolysaccharidoses in Germany. J Inherit Metab Dis 2005;28:1011-1017. https://doi.org/10.1007/s10545-005-0112-z
  3. Nelson J, Crowhurst J, Carey B, Greed L. Incidence of the mucopolysaccharidoses in Western Australia. Am J Med Genet A 2003;123A:310-313. https://doi.org/10.1002/ajmg.a.20314
  4. Vieira T, Schwartz I, Munoz V, Pinto L, Steiner C, Ribeiro M, Boy R, Ferraz V, de Paula A, Kim C, Acosta A, Giugliani R. Mucopolysaccharidoses in Brazil: what happens from birth to biochemical diagnosis? Am J Med Genet A 2008;146A:1741-1747. https://doi.org/10.1002/ajmg.a.32320
  5. Nelson J. Incidence of the mucopolysaccharidoses in Northern Ireland. Hum Genet 1997;101:355-358. https://doi.org/10.1007/s004390050641
  6. Wraith JE. The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I. Expert Opin Pharmacother 2005;6:489-506. https://doi.org/10.1517/14656566.6.3.489
  7. Keith O, Scully C, Weidmann GM. Orofacial features of Scheie (Hurler-Scheie) syndrome (${\alpha}$-L-iduronidase deficiency). Oral Surg Oral Med Oral Pathol 1990;70:70-74. https://doi.org/10.1016/0030-4220(90)90181-Q
  8. Kahler SG. Atlas of clinical syndromes: a visual aid to diagnosis for clinicians and practicing physicians. JAMA 1993;269:1050. https://doi.org/10.1001/jama.1993.03500080102045
  9. Simmons MA, Bruce IA, Penney S, Wraith E, Rothera MP. Otorhinolaryngological manifestations of the mucopolysaccharidoses. Int J Pediatr Otorhinolaryngol 2005;69:589-595. https://doi.org/10.1016/j.ijporl.2005.01.017
  10. de Santana Sarmento DJ, de Carvalho SH, Melo SL, Fonseca FR, Diniz DN, Bento PM, Mesquita GQ, de Melo DP. Mucopolysaccharidosis: radiographic findings in a series of 16 cases. Oral Surg Oral Med Oral Pathol Oral Radiol 2015;120:e240-e246. https://doi.org/10.1016/j.oooo.2015.08.009
  11. Guven G, Cehreli ZC, Altun C, Sencimen M, Ide S, Bayari SH, Karacay S. Mucopolysaccharidosis type I (Hurler syndrome): oral and radiographic findings and ultrastructural/chemical features of enamel and dentin. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008;105:72-78. https://doi.org/10.1016/j.tripleo.2007.02.015
  12. Hingston EJ, Hunter ML, Hunter B, Drage N. Hurler's syndrome: dental findings in a case treated with bone marrow transplantation in infancy. Int J Paediatr Dent 2006;16:207-212. https://doi.org/10.1111/j.1365-263X.2006.00712.x
  13. Kantaputra PN, Kayserili H, Guven Y, Kantaputra W, Balci MC, Tanpaiboon P, Uttarilli A, Dalal A. Oral manifestations of 17 patients affected with mucopolysaccharidosis type VI. J Inherit Metab Dis 2014;37:263-268. https://doi.org/10.1007/s10545-013-9645-8
  14. Hobbs JR, Hugh-Jones K, Barrett AJ, Byrom N, Chambers D, Henry K, James DC, Lucas CF, Rogers TR, Benson PF, Tansley LR, Patrick AD, Mossman J, Young EP. Reversal of clinical features of Hurler's disease and biochemical improvement after treatment by bone-marrow transplantation. Lancet 1981;2:709-712.
  15. Staba SL, Escolar ML, Poe M, Kim Y, Martin PL, Szabolcs P, Allison-Thacker J, Wood S, Wenger DA, Rubinstein P, Hopwood JJ, Krivit W, Kurtzberg J. Cord-blood transplants from unrelated donors in patients with Hurler's syndrome. N Engl J Med 2004;350:1960-1969. https://doi.org/10.1056/NEJMoa032613
  16. Fonseca FR, de Santana Sarmento DJ, Vasconcelos Medeiros PF, Diniz DN, dos Santos MT. Patients with mucopolysaccharidosis have tendencies towards vertical facial growth. J Oral Maxillofac Surg 2014;72:2539-2546. https://doi.org/10.1016/j.joms.2014.07.006
  17. Oussoren E, Brands MM, Ruijter GJ, der Ploeg AT, Reuser AJ. Bone, joint and tooth development in mucopolysaccharidoses: relevance to therapeutic options. Biochim Biophys Acta 2011;1812:1542-1556. https://doi.org/10.1016/j.bbadis.2011.07.013
  18. Alpoz AR, Coker M, Celen E, Ersin NK, Gokcen D, van Diggelenc OP, Huijmansc JG. The oral manifestations of Maroteaux-Lamy syndrome (mucopolysaccharidosis VI): a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;101:632-637. https://doi.org/10.1016/j.tripleo.2005.06.023
  19. Nakamura T, Miwa K, Kanda S, Nonaka K, Anan H, Higash S, Beppu K. Rosette formation of impacted molar teeth in mucopolysaccharidoses and related disorders. Dentomaxillofac Radiol 1992;21:45-49. https://doi.org/10.1259/dmfr.21.1.1397452
  20. Pastores GM, Arn P, Beck M, Clarke JT, Guffon N, Kaplan P, Muenzer J, Norato DY, Shapiro E, Thomas J, Viskochil D, Wraith JE. The MPS I registry: design, methodology, and early findings of a global disease registry for monitoring patients with mucopolysaccharidosis type I. Mol Genet Metab 2007;91:37-47. https://doi.org/10.1016/j.ymgme.2007.01.011
  21. Pennock CA, Barnes IC. The mucopolysaccharidoses. J Med Genet 1976;13:169-181. https://doi.org/10.1136/jmg.13.3.169
  22. Thomas S, Tandon S. Hurler syndrome: a case report. J Clin Pediatr Dent 2000;24:335-338. https://doi.org/10.17796/jcpd.24.4.ku653u75nv5vt735
  23. Glober GA, Tanaka KR, Turner JA, Liu CK. Mucopolysaccharidosis, an unusual cause of cardiac valvular disease. Am J Cardiol 1968;22:133-136. https://doi.org/10.1016/0002-9149(68)90256-7
  24. Wadenya RO, Stout AM, Gupta A, Monge J. Hurler syndrome: a case report of a 5-year follow-up of dental findings after bone marrow transplantation. Spec Care Dentist 2010;30:14-17. https://doi.org/10.1111/j.1754-4505.2009.00115.x